Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Chemopreventive Effects of Ferulic Acid and 3-ethyl(4¡¯-geranyloxy-3-methoxyphenyl)-2-propenoate (EGMP) on Colon Carcinogenesis in Rats Treated with Azoxymethane

´ëÇѾϿ¹¹æÇÐȸÁö 2000³â 5±Ç 4È£ p.193 ~ 198
¹Úö¹ü, ±è´ëÁß, ÀÌÁؼ·,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Úö¹ü ( Park Cheol-Beom ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ START ÀÇÇнùķ¹À̼Ǽ¾ÅÍ

±è´ëÁß ( Kim Dae-Joong ) 
Chungbuk National University College of Veterinary Medicine
ÀÌÁؼ· ( Lee Joon-Sup ) 
¼­¿ï´ëÇб³ ¼öÀÇ°ú´ëÇÐ

Abstract


The influence of ferulic acid (FA) and 3-ethyl (4-geranyloxy-3-methoxyphenyl)-2- propenoate (EGMP) on the post-initiation stages of colon carcinogenesis was investigated in male F344 rats treated with azoxymethane (AOM). FA and EGMP were given in the diet at 0.1 or 0.2% starting at week 3 after with two s.c. 15mg/kg body weight injections of AOM on days 1 and 7. Sacrifice for quantitation of aberrant crypt foci (ACF) was performed at the end of week 5. Dose-dependent decreases in numbers of ACF were noted with EGMP cases of post-initiation exposure, large size lesions feeding considered most likely to be precursor lesions also being significantly reduced. In contrast, only feeding 0.2% FA diet had exert inhibiting effect on the incidence of ACF. No effects on body or liver weights were evident. Thus our present results suggest that EGMP may have a potential cancer chemopreventive agent in rat colon carcinogenesis model.

Å°¿öµå

Ferulic acid; 3-Ethyl (4-geranyloxy-3-methoxyphenyl)-2-propenoate (EGMP); Synthetic ferulic acid derivative; Colon carcinogenesis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸